 <h1>Neo-Synephrine Ophthalmic Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>phenylephrine ophthalmic</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about phenylephrine ophthalmic. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Neo-Synephrine Ophthalmic.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to phenylephrine ophthalmic: ophthalmic solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, phenylephrine ophthalmic (the active ingredient contained in Neo-Synephrine Ophthalmic) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>Check with your doctor as soon as possible if any of the following side effects occur while taking phenylephrine ophthalmic:</p><p>
<i>Symptoms of too much medicine being absorbed into the body</i>
</p><ul>
<li>Dizziness</li>
<li> fast, irregular, or pounding heartbeat</li>
<li>increased sweating</li>
<li>increase in blood pressure</li>
<li>paleness</li>
<li>trembling</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of phenylephrine ophthalmic may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common with 2.5 or 10% solution</i>
</p><ul>
<li>Burning or stinging of eyes</li>
<li>headache or browache</li>
<li>sensitivity of eyes to light</li>
<li>watering of eyes</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Eye irritation not present before use of this medicine</li>
</ul><p>
<!-- end ophthalmic solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to phenylephrine ophthalmic: ophthalmic solution</i></p><h3>General</h3><p>The more commonly reported adverse reactions have included eye pain and stinging on instillation, temporary blurred vision and photophobia.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>There have been reports of serious cardiovascular reactions including ventricular arrhythmias and myocardial infarctions.  Fatalities have been reported.  Significant blood pressure elevations have been reported with recommended doses of 10% ophthalmic solution.</p><p><b>Frequency not reported</b>: Ventricular arrhythmias, myocardial infarction, hypertension, syncope, tachycardia, arrhythmia, palpitations, extrasystoles, reflex bradycardia, coronary artery spasm</p><h3>Ocular</h3><p>Periorbital pallor has been reported in preterm patients.</p><p><b>Frequency not reported</b>: Eye pain and stinging on instillation, temporary blurred vision, photophobia, conjunctival allergy, reactive hyperemia, transient punctuate keratitis, lacrimation, corneal edema, pigmented aqueous floaters, rebound conjunctival vasoconstriction, rebound miosis, periorbital pallor</p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity</p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Blanching of skin, increased perspiration</p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Subarachnoid hemorrhage, headache, tremor or trembling, aneurisms</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Phenylephrine Ophthalmic (phenylephrine ophthalmic)." Akorn Inc, Buffalo Grove, IL. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Neo-Synephrine (phenylephrine ophthalmic)" Sanofi Winthrop Pharmaceuticals, New York, NY. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Neo-Synephrine Ophthalmic (phenylephrine ophthalmic)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: mydriatics</li>
</ul>
<h3>Consumer resources</h3>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Mydfrin, Prefrin, AK-Dilate, Altafrin, ... +2 more</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Neo-Synephrine Injection</li>
<li>Neo-Synephrine Nasal</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Eye Redness</li>
<li>Pupillary Dilation</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to phenylephrine ophthalmic: ophthalmic solution</i></p><h3>General</h3><p>The more commonly reported adverse reactions have included eye pain and stinging on instillation, temporary blurred vision and photophobia.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>There have been reports of serious cardiovascular reactions including ventricular arrhythmias and myocardial infarctions.  Fatalities have been reported.  Significant blood pressure elevations have been reported with recommended doses of 10% ophthalmic solution.</p><p><b>Frequency not reported</b>: Ventricular arrhythmias, myocardial infarction, hypertension, syncope, tachycardia, arrhythmia, palpitations, extrasystoles, reflex bradycardia, coronary artery spasm</p><h3>Ocular</h3><p>Periorbital pallor has been reported in preterm patients.</p><p><b>Frequency not reported</b>: Eye pain and stinging on instillation, temporary blurred vision, photophobia, conjunctival allergy, reactive hyperemia, transient punctuate keratitis, lacrimation, corneal edema, pigmented aqueous floaters, rebound conjunctival vasoconstriction, rebound miosis, periorbital pallor</p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity</p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Blanching of skin, increased perspiration</p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Subarachnoid hemorrhage, headache, tremor or trembling, aneurisms</p><p id="ref_1">1. "Product Information. Phenylephrine Ophthalmic (phenylephrine ophthalmic)." Akorn Inc, Buffalo Grove, IL. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Neo-Synephrine (phenylephrine ophthalmic)" Sanofi Winthrop Pharmaceuticals, New York, NY. </p><h2>More about Neo-Synephrine Ophthalmic (phenylephrine ophthalmic)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: mydriatics</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Neo-Synephrine Injection</li>
<li>Neo-Synephrine Nasal</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Eye Redness</li>
<li>Pupillary Dilation</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>